Condition: Hepatocellular Carcinoma · Sponsor: Canadian Cancer Trials Group
The purpose of this study is to compare the effects on participants' and liver cancer by adding a drug that is used on its own to treat this disease to a combination of two other drugs which is also used to treat liver cancer, compared to the two-drug combination alone.
This description comes directly from the study's public registry record.
Chris O'Callaghan · 613-533-6430 · cocallaghan@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary, Alberta, Canada | Recruiting |
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton, Ontario, Canada | Recruiting |
| Kingston Health Sciences Centre | Kingston, Ontario, Canada | Recruiting |
| Waterloo Regional Health Network (WRHN) | Kitchener, Ontario, Canada | Recruiting |
| London Health Sciences Centre Research Inc. | London, Ontario, Canada | Recruiting |
| Trillium Health Partners - Credit Valley Hospital | Mississauga, Ontario, Canada | Recruiting |
| Ottawa Hospital Research Institute | Ottawa, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| CHUM-Centre Hospitalier de l'Universite de Montreal | Montreal, Quebec, Canada | Recruiting |
| The Jewish General Hospital | Montreal, Quebec, Canada | Recruiting |
| Saskatoon Cancer Centre | Saskatoon, Saskatchewan, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06880523